Annexon (ANNX) Total Current Liabilities (2019 - 2026)
Annexon's (ANNX) quarterly Total Current Liabilities came in at $35.9 million in Q1 2026, up 7.12% year-on-year from $33.5 million in Q1 2025, and down 15.7% quarter-over-quarter from $42.6 million in Q4 2025.
Annexon (ANNX) Total Current Liabilities (2019 - 2026) Analysis & Trends
Annexon's Total Current Liabilities history runs 8 years deep, the most recent figure standing at $35.9 million for Q1 2026.
- On a quarterly basis, Total Current Liabilities rose 7.12% year-over-year to $35.9 million in Q1 2026; TTM through Mar 2026 was $35.9 million, a 7.12% increase from a year earlier, with the FY2025 full-year figure at $42.6 million, up 39.72% from the prior year.
- Total Current Liabilities declined to $35.9 million in Q1 2026 per ANNX's latest filing, from $42.6 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $43.6 million in Q3 2025 and bottomed at $13.1 million in Q1 2024.
- The 5-year median for Total Current Liabilities is $20.3 million (2022), against an average of $25.5 million.
- Across the five-year window, Total Current Liabilities slumped 42.75% in 2024 and soared 155.44% in 2025, its largest moves.
- Year by year, Total Current Liabilities stood at $22.4 million in 2022, then retreated by 19.82% to $17.9 million in 2023, then surged by 70.19% to $30.5 million in 2024, then soared by 39.72% to $42.6 million in 2025, then declined by 15.7% to $35.9 million in 2026.
- Per Business Quant, the three latest ANNX Total Current Liabilities figures stand at $35.9 million (Q1 2026), $42.6 million (Q4 2025), and $43.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 56.01 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 66.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.81 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 6.38 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 3.88 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.11 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.58 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 289.60 Mn |
| 10 | Annexon | 1.03 Bn | 804.24 Mn | - | 35.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35.94 Mn |
| Dec 31, 2025 | 42.63 Mn |
| Sep 30, 2025 | 43.58 Mn |
| Jun 30, 2025 | 40.64 Mn |
| Mar 31, 2025 | 33.55 Mn |
| Dec 31, 2024 | 30.51 Mn |
| Sep 30, 2024 | 20.05 Mn |
| Jun 30, 2024 | 17.15 Mn |
| Mar 31, 2024 | 13.13 Mn |
| Dec 31, 2023 | 17.93 Mn |
| Sep 30, 2023 | 17.17 Mn |
| Jun 30, 2023 | 17.89 Mn |
| Mar 31, 2023 | 22.94 Mn |
| Dec 31, 2022 | 22.36 Mn |
| Sep 30, 2022 | 20.22 Mn |
| Jun 30, 2022 | 20.25 Mn |
| Mar 31, 2022 | 17.05 Mn |
| Dec 31, 2021 | 21.74 Mn |
| Sep 30, 2021 | 11.92 Mn |
| Jun 30, 2021 | 10.28 Mn |